Repression of small heterodimer partner by NR5A2 affects VLDL synthesis and secretion and is deregulated in NAFLD as summarized in the seminal review of Bechmann and colleagues39. The gene discussed is NR5A2; the disease is metabolic dysfunction-associated steatotic liver disease.